Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Amyloid Fibrils03:03

Amyloid Fibrils

12.1K
Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining,...
12.1K
Point and Frameshift Mutations01:30

Point and Frameshift Mutations

1.3K
Point mutations are genetic alterations involving the change of a single nucleotide base pair in DNA. Depending on how the alteration affects protein synthesis, they can lead to various consequences.Point mutations fall into the following types:Silent mutations occur when a nucleotide change does not alter the amino acid sequence due to the redundancy of the genetic code. For instance, changing ACC to ACA still encodes threonine, leaving the protein function unaffected. This occurs because...
1.3K
Protein Organization01:24

Protein Organization

9.8K
Proteins are polymers of amino acid residues. They are versatile and responsible for different cellular functions, including DNA replication, molecular transport, catalysis, and structural support. Proteins have a hierarchical structure comprising at least three levels of organization: primary, secondary, and tertiary structure. Some large proteins have a quaternary structure where individual protein subunits are linked together.
The primary structure of a protein is its amino acid sequence....
9.8K
Mutations01:39

Mutations

94.9K
Overview
94.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

hexABC seeking the physical code of DNA.

Nature communications·2026
Same author

Decoding Cancer-Associated Mutations in DNA Polymerase η through Atomistic Simulations.

Journal of chemical theory and computation·2026
Same author

Structural and functional role of the magnesium ion in the human oxytocin receptor.

Journal of inorganic biochemistry·2026
Same author

Screening assay to monitor mono-ADP-ribosylhydrolase activity of viral macrodomains in cells.

Communications biology·2026
Same author

pH-dependent structural dynamics of neuropeptide Y in aqueous solution.

PloS one·2026
Same author

Protonation-dependent substrate release in a bacterial homolog of vesicular glutamate.

Biophysical journal·2026

Related Experiment Video

Updated: Feb 24, 2026

Investigating the Spreading and Toxicity of Prion-like Proteins Using the Metazoan Model Organism C. elegans
12:57

Investigating the Spreading and Toxicity of Prion-like Proteins Using the Metazoan Model Organism C. elegans

Published on: January 8, 2015

16.6K

Structural Modeling of Human Prion Protein's Point Mutations.

Giulia Rossetti1, Paolo Carloni2

  • 1Institute of Neuroscience and Medicine (INM-9) and Institute for Advanced Simulation (IAS-5), Jülich, Germany; Jülich Supercomputing Centre, Jülich, Germany; University Hospital Aachen, RWTH-Aachen, Aachen, Germany.

Progress in Molecular Biology and Translational Science
|August 26, 2017
PubMed
Summary

Prion diseases stem from the misfolding of prion proteins (PrPC) into pathogenic forms (PrPSc). Molecular simulations reveal mutation "hot spots" and identify key helical regions prone to this conversion, aiding understanding of these fatal neurodegenerative conditions.

Keywords:
Disease-linked mutationsMolecular dynamic simulationsN-terminal domainPrion protein

More Related Videos

Isolation of Soluble and Insoluble PrP Oligomers in the Normal Human Brain
11:29

Isolation of Soluble and Insoluble PrP Oligomers in the Normal Human Brain

Published on: October 3, 2012

11.3K
Purification of Hsp104, a Protein Disaggregase
07:17

Purification of Hsp104, a Protein Disaggregase

Published on: September 30, 2011

17.8K

Related Experiment Videos

Last Updated: Feb 24, 2026

Investigating the Spreading and Toxicity of Prion-like Proteins Using the Metazoan Model Organism C. elegans
12:57

Investigating the Spreading and Toxicity of Prion-like Proteins Using the Metazoan Model Organism C. elegans

Published on: January 8, 2015

16.6K
Isolation of Soluble and Insoluble PrP Oligomers in the Normal Human Brain
11:29

Isolation of Soluble and Insoluble PrP Oligomers in the Normal Human Brain

Published on: October 3, 2012

11.3K
Purification of Hsp104, a Protein Disaggregase
07:17

Purification of Hsp104, a Protein Disaggregase

Published on: September 30, 2011

17.8K

Area of Science:

  • Neuroscience
  • Biochemistry
  • Structural Biology

Background:

  • Prion diseases, or transmissible spongiform encephalopathies, are rare, fatal neurodegenerative disorders affecting humans and animals.
  • Disease pathogenesis involves the conversion of cellular prion protein (PrPC) to a misfolded, pathogenic isoform (PrPSc).
  • Specific mutations can trigger spontaneous conversion, leading to disease.

Purpose of the Study:

  • To investigate the structural effects of disease-linked mutations on human prion protein (PrPC) using molecular simulations.
  • To identify critical regions and "hot spots" within PrPC that are susceptible to pathogenic conversion.
  • To correlate computational findings with existing experimental data on prion protein misfolding.

Main Methods:

  • Utilized molecular simulation studies on wild-type and mutant human PrPC variants.
  • Analyzed protein structures to pinpoint regions prone to misfolding and conversion.
  • Compared simulation results with experimental data to validate findings.

Main Results:

  • Molecular simulations provided a consistent view of how mutations affect PrPC structure.
  • Identified specific "hot spots" for conversion in several disease-linked PrPC variants.
  • Pinpointed a region comprising Helix 2 and Helix 3 as particularly susceptible to pathogenic conversion, aligning with experimental evidence.

Conclusions:

  • Molecular simulations are valuable tools for understanding prion protein misfolding mechanisms.
  • Specific structural regions, notably Helix 2 and Helix 3, are crucial in the pathogenesis of prion diseases.
  • These findings contribute to a deeper understanding of the molecular basis of prion diseases and may inform future therapeutic strategies.